Colonial Trust Advisors Bristol Myers Squibb CO Transaction History

Colonial Trust Advisors

$1.14 Billion
Q3 2024

A detailed history of Colonial Trust Advisors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Colonial Trust Advisors holds 5,494 shares of BMY stock, worth $310,795. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,494

Previous 5,494 -0.0%

Holding current value

$310,795

Previous $228,000 24.56%

% of portfolio

0.02%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $1,247 - $1,642	31 Added 0.57%	5,494 $228,000
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $19,815 - $22,467	-413 Reduced 7.03%	5,463 $296,000
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $48,043 - $57,329	-991 Reduced 14.43%	5,876 $301,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $58,353 - $65,247	-1,008 Reduced 12.8%	6,867 $398,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $64,028 - $71,093	-1,005 Reduced 11.32%	7,875 $503,000
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $195,750 - $222,024	2,979 Added 50.48%	8,880 $615,000
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $46,155 - $54,654	-674 Reduced 10.25%	5,901 $424,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $98 - $57,937	754 Added 12.95%	6,575 $467,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $46,818 - $54,579	-873 Reduced 13.04%	5,821 $363,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $8,875 - $10,396	-150 Reduced 2.19%	6,694 $396,000
Q2 2021 Aug 05, 2021	SELL	$61.91 - $67.42 $52,623 - $57,307	-850 Reduced 11.05%	6,844 $457,000
Q1 2021 May 10, 2021	BUY	$59.34 - $66.74 $1,068 - $1,201	18 Added 0.23%	7,694 $486,000
Q4 2020 Jan 29, 2021	BUY	$57.74 - $65.43 $23,096 - $26,172	400 Added 5.5%	7,676 $476,000
Q3 2020 Oct 26, 2020	BUY	$57.43 - $63.64 $45,944 - $50,912	800 Added 12.35%	7,276 $439,000
Q2 2020 Aug 10, 2020	BUY	$54.82 - $64.09 $26,149 - $30,570	477 Added 7.95%	6,476 $381,000
Q3 2019 Nov 15, 2019	BUY	$42.77 - $50.71 $15,012 - $17,799	351 Added 6.21%	5,999 $304,000
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $25,944 - $30,935	575 Added 11.33%	5,648 $269,000
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $27,988 - $36,294	-574 Reduced 10.16%	5,073 $264,000
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $99,176 - $111,863	-1,797 Reduced 24.14%	5,647 $351,000
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $29,509 - $36,780	-584 Reduced 7.27%	7,444 $412,000
Q1 2018 May 10, 2018	SELL	$59.92 - $68.98 $160,286 - $184,521	-2,675 Reduced 24.99%	8,028 $508,000
Q4 2017 Feb 21, 2018	BUY	$59.94 - $65.35 $178,261 - $194,350	2,974 Added 38.48%	10,703 $656,000
Q2 2017 Aug 14, 2017	BUY	N/A	7,729	7,729 $431,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust Advisors with notifications on news.

Account

Colonial Trust Advisors Bristol Myers Squibb CO Transaction History